FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
levonordefrin; procaine hydrochloride; propoxycaine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1952
NDA
30/100
RAXAR
grepafloxacin hydrochloride
LOE Approaching
OtsukaOtsuka
ORAL · TABLET
1997
NDA
30/100
RAZADYNE
galantamine hydrobromide
LOE Approaching
J&
Johnson & Johnson
ORAL · TABLET
mild to moderate dementia of the Alzheimer's type
2001
NDA
30/100
RAZADYNE
galantamine hydrobromide
LOE Approaching
J&
Johnson & Johnson
ORAL · SOLUTION
mild to moderate dementia of the Alzheimer's type
2001
NDA
30/100
RAZADYNE ER
galantamine hydrobromide
LOE Approaching
J&
Johnson & Johnson
ORAL · CAPSULE, EXTENDED RELEASE
mild to moderate dementia of the Alzheimer's typemild to moderate dementia of the Alzheimer’s type ()
2005
NDA
30/100
RBC-SCAN
technetium tc-99m red blood cell kit
LOE Approaching
AcadeMab BiomedicalAcadeMab Biomedical
INJECTION · INJECTABLE
1992
NDA
30/100
READI-CAT 2
barium sulfate
Peak
BraccoBracco
ORAL · SUSPENSION
2016
NDA
30/100
READI-CAT 2 SMOOTHIE
barium sulfate
Peak
BraccoBracco
ORAL · SUSPENSION
2016
NDA
30/100
READYPREP CHG
chlorhexidine gluconate 2%
Peak
TOPICAL · CLOTH
2018
NDA
30/100
REBETOL
ribavirin
LOE Approaching
M&
Merck & Co.
ORAL · CAPSULE
hospitalized infantsyoung children with severe lower respiratory tract infections due to RSV
1998
NDA
30/100
REBETOL
ribavirin
LOE Approaching
M&
Merck & Co.
ORAL · SOLUTION
hospitalized infantsyoung children with severe lower respiratory tract infections due to RSV
2003
NDA
30/100
RECLAST
zoledronic acid
LOE Approaching
NovartisNovartis
INJECTION · INJECTABLE
2007
NDA
30/100
RECTIV
nitroglycerin
Peak
AbbVieAbbVie
INTRA-ANAL · OINTMENT
2011
NDA
30/100
REDITREX
methotrexate
Peak
Nordic PharmaNordic Pharma
SUBCUTANEOUS · SOLUTION
2019
NDA
30/100
REGITINE
phentolamine mesylate
LOE Approaching
NovartisNovartis
INJECTION · INJECTABLE
1952
NDA
30/100
REGLAN
metoclopramide hydrochloride
LOE Approaching
ANI PharmaceuticalsANI Pharmaceuticals
ORAL · TABLET
1980
NDA
30/100
REGLAN
metoclopramide hydrochloride
LOE Approaching
HikmaHikma
INJECTION · INJECTABLE
1979
NDA
30/100
REGLAN
metoclopramide hydrochloride
LOE Approaching
ORAL · SOLUTION
1983
NDA
30/100
REGLAN ODT
metoclopramide hydrochloride
LOE Approaching
Viatris (2)Viatris (2)
ORAL · TABLET, ORALLY DISINTEGRATING
2005
NDA
30/100
REGROTON
chlorthalidone; reserpine
LOE Approaching
SanofiSanofi
ORAL · TABLET
1964
NDA
30/100
RELAFEN
nabumetone
LOE Approaching
GSKGSK
ORAL · TABLET
1991
NDA
30/100
RELENZA
zanamivir
LOE Approaching
GSKGSK
INHALATION · POWDER
1999
SMNDA
30/100
RELPAX
eletriptan hydrobromide
LOE Approaching
Viatris (2)Viatris (2)
ORAL · TABLET
2002
NDA
30/100
REMERON
mirtazapine
LOE Approaching
M&
Merck & Co.
ORAL · TABLET
1996
NDA
30/100
← PreviousPage 151 of 277Next →